ACADIA PHARMACEUTICALS INC (ACAD) Operating margin 2016–2025
ACADIA PHARMACEUTICALS INC (ACAD) operating margin by fiscal year — reported operating income divided by reported revenue.
9.8%FY2025 · since FY2016: -1574.1% → 9.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 9.8% | -14.3 pp |
| FY2024 | 24.1% | +34.2 pp |
| FY2023 | -10.1% | +33.1 pp |
| FY2022 | -43.2% | -8.0 pp |
| FY2021 | -35.2% | +29.7 pp |
| FY2020 | -64.9% | +7.8 pp |
| FY2019 | -72.7% | +37.9 pp |
| FY2018 | -110.6% | +123.6 pp |
| FY2017 | -234.1% | +1340.0 pp |
| FY2016 | -1574.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice